The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome

Abstract Background Although immune modulation is a promising therapeutic avenue in coronavirus disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has peculiar characteristics and outcomes, suggesting a unique immunopathogenesis. Methods Thirty-six immunocompetent non-CO...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Mathieu Blot, Jean-Baptiste Bour, Jean Pierre Quenot, Abderrahmane Bourredjem, Maxime Nguyen, Julien Guy, Serge Monier, Marjolaine Georges, Audrey Large, Auguste Dargent, Alexandre Guilhem, Suzanne Mouries-Martin, Jeremy Barben, Belaid Bouhemad, Pierre-Emmanuel Charles, Pascal Chavanet, Christine Binquet, Lionel Piroth, for the LYMPHONIE study group
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2020-12-01
Sarja:	Journal of Translational Medicine
Aiheet:	COVID-19 Acute respiratory distress syndrome Pneumonia Immune response CXCL10 GM-CSF
Linkit:	https://doi.org/10.1186/s12967-020-02646-9
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!